Pharmacology

When Endometrial Surgery Isn't Enough

Surgery for endometriosis isn’t always curative, and often other measures, such as aromatase inhibitors and progestins, are needed postoperatively to prevent recurrence. However, drug adverse effects can make it hard for patients to adhere to long-term treatment. One solution may be a levonorgestrel-releasing intrauterine system (IUS), suggest researchers from MahidolUniversity, Bangkok, Thailand. These researchers suggest it would release the drug more slowly, potentially reducing adverse effects, and would render the compliance issue moot for at least 5 years.


 

Recommended Reading

A Pain Education School for Veterans: Putting Prevention Into VA Practice
Federal Practitioner
Embedding Dermatology in a VA Geriatric Primary Care Clinic
Federal Practitioner
A 37-Year-Old Man With Symptoms of Fatigue, Malaise, and Dizziness
Federal Practitioner
Meetings and Events
Federal Practitioner
All 152 VA Medical Centers Now on Facebook
Federal Practitioner
Veterans Now Eligible for Insurance Coverage Increase
Federal Practitioner
New Fact Sheet About Diabetes Screening
Federal Practitioner
Flu Pandemic Guidelines Established
Federal Practitioner
First Anniversary for VA Caregivers Support Line
Federal Practitioner
Drug Approved for Toxic Levels of Methotrexate
Federal Practitioner